Minister of Mental Health and Addictions and Associate Minister of Health Pocket Book

Table of Contents

A: Health Portfolio overview highlights

Portfolio organizations

Deputy Minister and Agency Heads

2021-22 Budget and full-time equivalents (FTEs)

The COVID-19 pandemic

Health of Canadians

Health system in Canada

Mental health and substance use

Federal health regulation

Health Research and Innovation in Canada

B: Health Portfolio responsibilities

C: The Portfolio

Health Canada (HC)

Public Health Agency of Canada (PHAC)

Canadian Institutes of Health Research (CIHR)

Canadian Food Inspection Agency (CFIA)

Patented Medicine Prices Review Board (PMPRB)

D: Key messages

If pressed on specific issues:

E: Priority issues

Mental health


The COVID-19 pandemic has exacerbated the prevalence of mental health conditions, particularly among groups such as women, youth, and other Canadians who experience marginalization and/or have complex needs. Service availability and quality varies across the country and some people experience barriers in accessing services that meet their diverse needs.

Proposed responses:

Opioids / Substances


The COVID-19 pandemic has worsened the opioid overdose crisis and health outcomes of people who use substances. Toxic street drug supply, isolation, stress, and reduced access to services have contributed to an increase in harms and deaths. Additionally, stakeholders, advocates, and some jurisdictions have publicly called on the federal government to decriminalize personal drug possession in response to the overdose crisis.

Proposed responses:

F: Key contacts

Prime minister's office switchboard
Tel: 613-992-4211
Minister's office reception
Tel: 613-957-0200

Health Canada

Dr. Stephen Lucas
Deputy Minister
Tel: 613-957-0212

Heather Jeffrey
Associate Deputy Minister
Tel: 613-954-5904

Public Health Agency of Canada

Dr. Harpreet S. Kochhar
Tel: 613-946-3498

Dr. Theresa Tam
Chief Public Health Officer
Tel: 613-954-8524

Kathy Thompson
Executive Vice-President
Tel: 613-957-0277

Canadian Food Inspection Agency

Dr. Siddika Mithani
Tel: 613-773-6000

Canadian Institutes of Health Research

Dr. Michael J. Strong
Tel: 613-954-1808

Catherine MacLeod
Executive Vice-President
Tel: 343-542-1487

Patented Medicine Prices Review Board

Dr. Mitchell Levine
Tel: 613-288-9665

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: